Literature DB >> 1601022

Hormone-induced pancreatitis.

S Willemer1, H P Elsässer, G Adler.   

Abstract

Intravenous infusion of the synthetic cholecystokinin analogue cerulein at a dose of 0.25 micrograms/kg/h causes maximal stimulation of pancreatic exocrine secretion. The infusion of supramaximal doses of cerulein (5 and 10 micrograms/kg/h) induces a significant increase in pancreatic enzymes in blood, and interstitial edema and inflammatory cell infiltration. This model of hormone-induced pancreatitis works in rats, mice, dogs and hamsters. Besides intravenous infusion, repeated intraperitoneal injections can also be used for induction of pancreatitis. In the early phase of cerulein-induced pancreatitis, large autophagic vacuoles result from fusion of zymogen granules within the acinar cell. This is accompanied by an increase in lysosomal enzyme activity and activation of trypsinogen which finally leads to cellular necrosis. All animals survive the induction of pancreatitis. The pancreas completely regenerates within 6 days after induction of pancreatitis. This model of experimental pancreatitis favors the analysis of intracellular events in the early phase of pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601022     DOI: 10.1159/000129237

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  49 in total

1.  Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.

Authors:  Kyoung Eun Lee; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

2.  Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.

Authors:  Jie Liao; Sung Hee Hwang; Haonan Li; Jun-Yan Liu; Bruce D Hammock; Guang-Yu Yang
Journal:  Anticancer Res       Date:  2016-01       Impact factor: 2.480

3.  Membrane proteome analysis of cerulein-stimulated pancreatic acinar cells: implication for early event of acute pancreatitis.

Authors:  Jangwon Lee; Ji Hye Seo; Joo Weon Lim; Hyeyoung Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

4.  Altered gene expression in cerulein-stimulated pancreatic acinar cells: pathologic mechanism of acute pancreatitis.

Authors:  Ji Hoon Yu; Joo Weon Lim; Hyeyoung Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

5.  Duration of injury correlates with necrosis in caerulein-induced experimental acute pancreatitis: implications for pathophysiology.

Authors:  Tony G Jacob; Rahul Raghav; Ajay Kumar; Pramod K Garg; Tara S Roy
Journal:  Int J Exp Pathol       Date:  2014-04-25       Impact factor: 1.925

6.  Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.

Authors:  Ahmed Bettaieb; Samah Chahed; Santana Bachaalany; Stephen Griffey; Bruce D Hammock; Fawaz G Haj
Journal:  Mol Pharmacol       Date:  2015-05-20       Impact factor: 4.436

7.  Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis.

Authors:  Hyeyoung Kim
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

8.  Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.

Authors:  Catherine Carrière; Alison L Young; Jason R Gunn; Daniel S Longnecker; Murray Korc
Journal:  Biochem Biophys Res Commun       Date:  2009-03-16       Impact factor: 3.575

9.  Pancreatic Protein Tyrosine Phosphatase 1B Deficiency Exacerbates Acute Pancreatitis in Mice.

Authors:  Ahmed Bettaieb; Shinichiro Koike; Samah Chahed; Santana Bachaalany; Stephen Griffey; Juan Sastre; Fawaz G Haj
Journal:  Am J Pathol       Date:  2016-07-20       Impact factor: 4.307

10.  Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.

Authors:  Jacqueline A Koehler; Laurie L Baggio; Benjamin J Lamont; Safina Ali; Daniel J Drucker
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.